John E. Elicker | Bristol-Myers Squibb Co. |
Giovanni Caforio | Bristol-Myers Squibb Co. |
Charles A. Bancroft | Bristol-Myers Squibb Co. |
Christopher S. Boerner | Bristol-Myers Squibb Co. |
Thomas James Lynch | Bristol-Myers Squibb Co. |
Alex Arfaei | BMO Capital Markets (United States) |
Jami Rubin | Goldman Sachs & Co. LLC |
Jason M. Gerberry | Bank of America Merrill Lynch |
Timothy Minton Anderson | Wolfe Research, LLC |
Chris Schott | JPMorgan Securities LLC |
Umer Raffat | Evercore Group LLC |
Matthew Phipps | William Blair & Co. LLC |
Seamus Fernandez | Guggenheim Securities LLC |
Andrew S. Baum | Citigroup Global Markets Ltd. |
Steve Scala | Cowen & Co. LLC |
John T. Boris | SunTrust Robinson Humphrey, Inc. |
Vamil K. Divan | Credit Suisse Securities (NYSE:USA) LLC |
Geoff Meacham | Barclays Capital, Inc. |
Good day and welcome to the Bristol-Myers Squibb 2018 third quarter results conference call. Today's call is being recorded. At this time I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.